PRMT3 and hepatocellular carcinoma: We found that PRMT3-KO or PRMT3 inhibition by SGC707 abolished the asymmetric dimethylarginine (ADMA) of HSP60 in both mouse and human HCC cells (Hepa1-6 and PLC-8024) (Fig. 4D and Supplementary Fig. 7J).